Clearside Biomedical, Inc.

Release Summary

Clearside Biomedical, a clinical-stage biopharmaceutical firm developing drugs for the eye, announces its 1st patient enrolled in Phase 3 trial for macular edema associated with non-infectious uveitis

Clearside Biomedical, Inc.